Drugs / Epo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02550054 | Sep 2015 → Dec 2016 | pulmonary immaturity | Children's Hospital of Fudan University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPO | “early administration of human erythropoietin (EPO) in preterm infants improves neurodevelopmental outcome at 18 months corrected age” NCT02550054 ↗ |
| Route | Intravenous | “Epo is administered 1000 U/kg, iv” NCT02550054 ↗ |